Zobrazeno 1 - 10
of 637
pro vyhledávání: '"Muh Hwa Yang"'
Autor:
Muh-Hwa Yang, Tien-Hua Chen, Hung-Ming Wang, Jason Chia-Hsun Hsieh, Huai-Cheng Huang, Meng-Che Hsieh, Chia-Jui Yen, Shang-Yin Wu, Chun-Hung Hua, Ming-Yu Lien, Yi-Fang Chang, Hui-Ching Wang, Chih-Yen Chien, Tai-Lin Huang, Hsueh-Ju Lu, Jin-Ching Lin, Chen-Chi Wang, Yi-Chun Liu, Jo-Pai Chen, Wei-Chen Lu, Ching-Yi Yiu, Chien-Liang Lin, Pei-Jen Lou, Pen-Yuan Chu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background In recent years, the addition of cetuximab to chemotherapy has improved treatment outcomes for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). In this study, we present the real-world survival
Externí odkaz:
https://doaj.org/article/c0bb5c565c1549cc89406fca96fbad68
Autor:
Kai-Wei Chang, Yen-Ying Kung, Shu-Ling Fu, Ju-Fang Liu, Kun-Chang Wu, Tzu-Hau Shi, Yu-Han Luo, Chao-Hsiung Lin, Jih-Jung Chen, Yueh-Hsin Ping, Tung-Hu Tsai, Muh-Hwa Yang
Publikováno v:
Journal of Functional Foods, Vol 122, Iss , Pp 106530- (2024)
Objective: MicroRNAs (RNA) are crucial in combating SARS-CoV-2; Some traditional Chinese herbal formulas (CHF) have shown potential against the original SARS-CoV-2 strain but no research explores CHF’s role in regulating microRNAs to combat the vir
Externí odkaz:
https://doaj.org/article/a3ae0aa038e548c4b898d4ba474ba8eb
Autor:
Wan-Hsin Lee, Yen-Ying Kung, Chung-Kai Sun, Chun-Hao Chang, Wen-Ya Peng, Lie-Chwen Lin, Chung-Hua Hsu, Muh-Hwa Yang, Tung-Hu Tsai
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e34820- (2024)
Aim of the study: Our hypothesis is that nirmatrelvir can penetrate the blood‒brain barrier and reach effective concentrations in the brain. Furthermore, herbal formulations can help maintain nirmatrelvir levels in the body, suggesting potential in
Externí odkaz:
https://doaj.org/article/3b2361bf19364f539dd420eba9d1aa5e
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Despite the utilization of immune checkpoint inhibitors (ICIs) in treating numerous types of cancers being approved, their efficacy in tumor control in the clinic is not satisfactory. Since adoptive cell therapy (ACT) can alter th
Externí odkaz:
https://doaj.org/article/38f0b792947040ed84789f39d8bf878b
Autor:
Chiao-En Wu, Yi-Hua Liao, Cheng-Lin Wu, Ruoh-Fang Yen, Chia-Chi Lin, Muh-Hwa Yang, Chueh-Chuan Yen, Wu-Chou Su, Chia-Jui Yen, Yi-Fang Chang, Ming-Fang Wu, Youngsen Yang, Chen-Yuan Lin, Wen-Chi Yang, Hui-Ching Wang, Cheng-Yuan Li, Yin-Yu Ho, Yao-Yu Chang, Chieh-Shan Wu, Hsiu-Cheng Hsu, Kuang-Hua Chen, Yenlin Huang, Chih-Jung Chen, Pei-Ju Chuang, Yung-Chi Lai, Yu-Yi Huang, Neng-Chuan Tseng, Yi-Ting Huang, Chia-Yu Chu, John Wen-Cheng Chang
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 1, Pp 7-15 (2024)
Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical
Externí odkaz:
https://doaj.org/article/04854f0faec04d159246a6f4a85d5aa9
Autor:
Chun-Hao Chang, Wen-Ya Peng, Wan-Hsin Lee, Ling Yang, Tung-Yi Lin, Muh-Hwa Yang, Tung-Hu Tsai
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-7 (2023)
Abstract Background The antiviral drug molnupiravir is an orally bioavailable prodrug of the nucleoside analog β-D-N4-hydroxycytidine (NHC), which is used to treat coronavirus disease 2019 (COVID-19). However, there is very little information on the
Externí odkaz:
https://doaj.org/article/4083a271a48c4439baf9c131e32988e1
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24333- (2024)
Background: Ritonavir is one of the most potent CYP3A4 inhibitor currently on the market, and is often used together with other antiviral drugs to increase their bioavailability and efficacy. Paxlovid, consisting of nirmatrelvir and ritonavir, was ap
Externí odkaz:
https://doaj.org/article/a7e69b23ca7b44748bcef709995ba261
Autor:
Chun-Hao Chang, Wen-Ya Peng, Wan-Hsin Lee, Tung-Yi Lin, Muh-Hwa Yang, Jeffrey W. Dalley, Tung-Hu Tsai
Publikováno v:
EBioMedicine, Vol 95, Iss , Pp 104748- (2023)
Summary: Background: Molnupiravir is an orally bioavailable prodrug of the nucleoside analogue β-D-N4-hydroxycytidine (NHC) and is used to treat coronavirus disease 2019 (COVID-19). However, the pharmacokinetics and transplacental transfer of molnup
Externí odkaz:
https://doaj.org/article/ea27156d271348a2a78f0ff4a9a7ce97
Autor:
Cheng‐Yu Tang, Jen‐Fan Hang, Yi‐Ping Hung, Nai‐Chi Chiu, Jiun‐I Lai, Ming‐Huang Chen, Chun‐Yu Liu, Muh‐Hwa Yang, Yee Chao, Peter Mu‐Hsin Chang
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1090-1101 (2023)
Abstract Background The prognosis of unfavorable cancer of unknown primary is extremely poor. This is the first report to compared the treatment results between generations of CUP and examined prognostic factors. Methods This retrospective single‐c
Externí odkaz:
https://doaj.org/article/5083ae094eaf4db9974114e04122f49f
Autor:
Tien-Hua Chen, Yi-Ying Pan, Tsung-Lun Lee, Ling-Wei Wang, Shyh-Kuan Tai, Pen-Yuan Chu, Wen-Liang Lo, Cheng-Hsien Wu, Muh-Hwa Yang, Peter Mu-Hsin Chang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Recurrent/ metastatic squamous cell carcinoma of head and neck (R/M SCCNH) is still a difficult-to-treat disease with poor clinical outcomes and limited treatment choices. In view of locoregional recurrent versus distant metastati
Externí odkaz:
https://doaj.org/article/7eaf5d8e89f447e0a4fd65ff438a6c73